Essity B 264.2 (+1.3 SEK) on 17-May-2022 15:19
Select region

Global Site

USA USA Russia Russia Germany Germany Mexico Mexico Netherlands Netherlands France France Sweden Sweden Italy Italy Spain Spain
Essity logo
Brands

Company

Essity at a Glance
Purpose and Vision Our Beliefs Our History
Business Areas
Health & Medical Consumer Goods Professional Hygiene Market and Trends Market Positions E-Commerce
Breaking Barriers to Well-being
Stories Partnerships Insights Events
Diversity, Equity and Inclusion
Strategy
Our Business Model Our Strategic Priorities
Organization and Management
Board of Directors CEO and EVP Business and Global Units Management Group Functions
Corporate Governance
Articles of Association General Meeting Nomination Committee Auditors Board and Committee Work Remuneration to the Board of Directors Remuneration Policy Public Policies Sustainability Governance
Risk Management
Essity in the World
Austria UK & ROI Belgium Poland

Brands

Sustainability

What We Do
How We Do It
Responsible Sourcing Resource-efficient Production Responsible Business
Why We Do It
Sustainable Development Goals Science Based Targets
Our Journey to Net zero
Key Action Areas Climate targets
Role in Society
Partnerships and Collaborations Essity in the Spotlight Ways of Working Trade Associations and Policy Organizations Public Policy Development Positions Advancing the Knowledge
Human Rights
Community Relations
Reporting and Data
Annual and Sustainablity Report Sustainability in Brief Essity Non-financial Reporting System Environmental Data Certification
Recognitions and Memberships
Contact Us

Innovation

Products and Solutions
Digitalization
Essity Ventures
Latest Innovations

Careers

Job Opportunities
Work at Essity
Commitment to Our Employees Diversity, Equity and Inclusion Learning and Development Why Choose Essity? Barrier Breakers
Students and Graduates
Graduates Students Internships Apprenticeships
Career Stories
Alumni Network
Connect with Us
Career Events
Total Rewards

Investors

Essity as an Investment
Targets and Outcomes
Essity Share
Data per Share Ownership Dividend List of Analysts Trade Information Share Conversion Share Capital Development Indexes
Financials
Reports
Interim Reports Annual Reports Prospectus
Presentations and Webcasts
Capital Markets Day 2021
Investor Day 2019
Debt Financing
Debt Programmes Credit Rating Funding Sources Key Debt Ratios
Essity Data
Acquisitions and Divestments
Investor Relations Calendar
Investor Relations Contacts
Subscribe

Media

Press Releases
News Features
Images & Video
Subscribe
Media Contact
Local Media Contacts
Essity in Social Media
Home
Media
Press releases
2021
Media
Press Releases News Features Images & Video Subscribe Media Contact Essity in Social Media

April 27, 2021

Essity acquires remaining shares in ABIGO Medical AB

Hygiene and health company Essity has signed an agreement today to acquire the remaining 25% of the shares in the Swedish medical solutions company ABIGO Medical AB. Essity acquired 75% of ABIGO Medical in February 2020. Following the acquisition, ABIGO Medical will be a wholly owned subsidiary of Essity in the product category Medical Solutions. The shares are being acquired from founder and chairman of the board Jan G. Smith at a valuation of SEK 900m for 100% of the company on a debt-free basis.

“We are very pleased with this acquisition, which is a natural step in our ambition to strengthen our positions in medical solutions. ABIGO has unique expertise and innovation capacity that will contribute to accelerating Essity’s growth in advanced wound care,” says Magnus Groth, President and CEO, Essity. 

ABIGO Medical AB is a Swedish medical solutions company with its head office in Gothenburg, Sweden, and was founded in 1989 by the brothers Jan G. and Leif Smith. The company has about 170 employees. ABIGO Medical AB develops, manufactures and markets products including the Sorbact® technology, which is a clinically established innovation for advanced wound care. In the first quarter of 2021, Essity’s organic net sales in wound care increased 2.1%.

In parallel with the acquisition, a process is under way to streamline ABIGO Medical’s operations. The parties have concluded an agreement in principle under which Jan G. Smith will, in the near future, acquire the pharma business comprising products such as ear and eye care as well as vitamins. 

“I have had a close relationship with Essity for many years and I am very confident that this is the right step in ABIGO’s journey of growth,” says Jan G. Smith.

Essity’s acquisition will be finalized in May 2021. 

Essity acquires remaining shares in ABIGO Medical AB
Back to press releases

Share this

Essity logo
Company Careers Brands Breaking Barriers Contact Us
Privacy Policy Cookies Terms and Conditions

Tel +46 8-788 51 00

© Essity Aktiebolag (publ). Box 200, SE-101 23, Stockholm, Sweden